Abiopharma

Abbotts Volt™ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial Fibrillation

Savara Inc. - Savara Resubmits the Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* for the Potential Treatment of Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)

Vivos Inc Summarzes Preogress in its Animal Therapy Division

Entera Bio Announces New Data Supporting Further Development of a Proprietary First-in-Class Oral, Long-Acting PTH Tablet for Patients with Hypoparathyroidism (EB612 Program)

CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel (Zugo-cel; formerly CTX112™) in Autoimmune Diseases and Hematologic Malignancies

CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference

Incyte Japan annuncia lapprovazione per Minjuvi® (tafasitamab) in combinazione con rituximab e lenalidomide nel trattamento del linfoma follicolare recidivante o refrattario

McKesson Corporation - Mckesson Corporation Announces Third Quarter Fiscal 2026 Earnings Release Date

Gilead - Gilead Sciences Exercises Option to License AssemblyBiosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes

TransCode Therapeutics Expands Leadership with Appointment of Jack E. Stover to Board of Directors